Evolution of the CCR5 δ32 mutation based on haplotype variation in Jewish and Northern European population samples

Human Immunology

Volumn 62, Issue 5, 2001, Pages 530-538

  Klitz, William ^a   Brautbar, Chaim ^b   Schito, Anna M ^c   Barcellos, Lisa F ^c   Oksenberg, Jorge R ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ashkenazi; CCR5; HIV; Poxvirus

Indexed keywords

CHEMOKINE RECEPTOR CCR5; ALPHA CHEMOKINE; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; JEW; NORMAL HUMAN; PRIORITY JOURNAL; ALLELE; CHROMOSOME 3; CLASSIFICATION; EUROPE; GENETIC SCREENING; GENETICS; MOLECULAR EVOLUTION;

ALLELES; CHEMOKINES, CXC; CHROMOSOMES, HUMAN, PAIR 3; EUROPE; EVOLUTION, MOLECULAR; GENE DELETION; GENE FREQUENCY; GENETIC SCREENING; HAPLOTYPES; HUMANS; JEWS; RECEPTORS, CCR5; VARIATION (GENETICS);

EID: 0034744304     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(01)00239-7     Document Type: Article

References (33)

1. Alkhatib G., Combadiere C., Broder C.C., Feng Y., Kennedy P.E., Murphy P.M., Berger E.A. CC CKR5 a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophages-tropic HIV-1 . Science. 272:1996;1955.
2. Dean M., Carrington M., Winkler C., Huttley G.A., Smith M.W., Allikmets R., Goedert J.J., Buchbinder S.P., Vittinghoff E., Gomperts E., Donfield S., Vlahov D., Kaslow R., Saah A., Rinaldo C., Detels R., O'Brien S.J. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study . Science. 273:1996;1856.
3. Dragic T., Litwin V., Allaway G.P., Martin S.R., Huang Y., Nagashima K.A., Cayanan C., Maddon P.J., Koup R.A., Moore J.P., Paxton W.A. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC- CKR-5. Nature. 381:1996;667.
4. Liu R., Paxton W.A., Choe S., Ceradini D., Martin S.R., Horuk R., MacDonald M.E., Stuhlmann H., Koup R.A., Landau N.R. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell. 86:1996;367.
5. Garred P., Madsen H., Petersen J., Marquart H., Hansen T., Sorensen S., Volck B., Svejgaard A., Andersen V. CC chemokine receptor 5 polymorphism in rheumatoid arthritis. J Rheumatol. 25:1998;1462.
6. Barcellos L.F., Schito A.M., Rimmler J.B., Vittinghoff E., Shih A., Lincoln R., Caillier S., Elkins M.K., Goodkin D.E., Haines J.L., Pericak-Vance M.A., Hauser S.L., Oksenberg J.R. CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Immunogenet. 51:2000;281.
7. Martinson J.J., Chapman N.H., Rees D.C., Liu Y.-T., Clegg J.B. Global distribution of the CCR5 gene 32-basepair deletion. Nature Genet. 16:1997;100.
8. Libert F., Cochaux P., Beckman G., Samson M., Aksenova M., Cao A., Czeizel A., Claustres M., de la Rua C., Ferrari M., Ferrec C., Glover G., Grinde B., Guran S., Kucinskas V., Lavinha J., Mercier B., Ogur G., Peltonen L., Rosatelli C., Schwartz M., Spitsyn V., Timar L., Beckman L., Vassart G., et al. The delta ccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe. Hum Mol Genet. 7:1998;399.
9. Magierowska M., Lepage V., Boubnova L., Carcassi C., Juan D., Djoulah S., El Chenawi F., Grunnet N., Halle L., Ivanova R., Jungerman M., Naumova E., Petrany G., Sonnerborg A., Stavropoulos C., Thorsby E., Vu-Trieu A., Debre P., Theodorou I., Charron D. Distribution of the CCR5 gene 32 base pair deletion and SDF1-3′A variant in healthy individuals from different populations. Immunogenet. 48:1998;417.
10. Mummidi S., Bamshad M., Ahuja S., Gonzalez E., Feuillet P.M., Begum K., Galvis M.C., Kostecki V., Valente A.J., Murthy K.K., Harot L., Dolan M.J., Allan J.S., Ahuja S.K. Evolution of human and non-human primate CC chemokine receptor 5 gene and mRNA. J Biol Chem. 275:2000;18946.
11. Carrington M., Kissner T., Gerrard B., Ivanov S., O'Brien S.J., Dean M. Novel alleles of the chemokine-receptor gene CCR5. Am J Hum Genet. 61:1997;1261.
12. Stephens J.C., Reich D.E., Goldstein D.B., Shin H.D., Smith M.W., Carrington M., Winkler C., Huttley G.A., Allikmets R., Schriml L., Gerrard B., Malasky M., Ramos M.D., Morlot S., Tzetis M., Oddoux C., di Giovine F.S., Nasioulas G., Chandler D., Aseev M., Hanson M., Kalaydjieva L., Glavac D., Gasparini P., Dean M., et al. Dating the origin of the CCR5-D32 AIDS-resistant allele by the coalescence of haplotypes. Am J Hum Genet. 62:1998;1507.
13. Amar A., Brautbar C., Motro U., Fisher T., Bonne-Tamir B., Israel S. Genetic variation of three tetrameric tandem repeats in four distinct Israeli ethnic groups. J Forensic Sci. 44:1999;983.
14. Bonne-Tamir B., Bodmer J.G., Bodmer W.F., Pickbourne P., Brautbar C., Gazit E., Nevo S., Zamir R. HLA polymorphism in Israel. 9. An overall comparative analysis. Tissue Antigens. 11:1978;235.
15. Roitberg-Tambur A., Witt C.S., Friedmann A., Safirman C., Sherman L., Battat S., Nelken D., Brautbar C. Comparative analysis of HLA polymorphism at the serologic and molecular level in Moroccan and Ashkenazi Jews. Tissue Antigens. 46:1995;104.
16. Amar A., Kwon O.J., Motro U., Witt C.S., Bonne-Tamir B., Gabison R., Brautbar C. Molecular analysis of HLA class II polymorphisms among different ethnic groups in Israel. Hum Immunol. 60:1999;723.
17. Martinez-Laso J., Gazit E., Gomez-Casado E., Morales P., Martinez-Quiles N., Alvarez M., Martin-Villa J.M., Fernandez V., Arnaiz-Villena A. HLA DR and DQ polymorphism in Ashkenazi and non-Ashkenazi Jews comparison with other Mediterraneans . Tissue Antigens. 47:1996;63.
18. Skorecki K., Selig S., Blazer S., Bradman R., Bradman N., Waburton P.J., Ismajlowicz M., Hammer M.F. Y chromosomes of Jewish priests. Nature. 385:1997;32.
19. Hammer M.F., Redd A.J., Wood E.T., Bonner M.R., Jarjanazi H., Karafet T., Santachiara-Benerecetti S., Oppenheim A., Jobling M.A., Jenkins T., Ostrer H., Bonne-Tamir B. Jewish and Middle Eastern non-Jewish populations share a common pool of Y-chromosome biallelic haplotypes. Proc Natl Acad Sci USA. 97:2000;6769.
20. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res. 16:1988;1215.
21. Kostrikis L.G., Huang Y., Moore J.P., Wolinsky S.M., Zhang L., Guo Y., Deutsch L., Phair J., Neumann A.U., Ho D.D. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nature Med. 4:1998;350.
22. Winkler C., Modi W., Smith M.W., Nelson G.W., Wu X., Carrington M., Dean M., Honjo T., Tashiro K., Yabe D., Buchbinder S., Vittinghoff E., Goedert J.J., O'Brien T.R., Jacobson L.P., Detels R., Donfield S., Willoughby A., Gomperts E., Vlahov D., Phair J., O'Brien S.J. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC) . Science. 279:1998;389.
23. Baur MP, Danilovs J: Population genetic analysis of HLA-A, B, C, DR and other genetic markers. In Terasaki PI (ed): Histocompatibility Testing. Los Angeles: UCLA Tissue Typing Laboratory, 1995.
24. Long J.C., Williams R.C., Urbank M. An E-M algorithm and testing strategy for multiple locus haplotypes. Am J Hum Genet. 56:1995;799.
25. Sokal RR, Rohlf FJ: Biometry, 3rd Ed. W.H. Freeman (ed.), New York, 1995.
26. Klitz W., Stephens J.C., Grote M., Carrington M. Discordant patterns of linkage disequilibrium of the peptide-transporter loci within the HLA class II region. Am J Hum Genet. 57:1995;1436.
27. Maayan S., Zhang L., Shinar E., Ho J., He T., Manni N., Kostrikis L.G., Neumann A.U. Evidence for recent selection of the CCR5-delta 32 deletion from differences in its frequency between Ashkenazi and Sephardi Jews. Genes Immun. 1:2000;358.
28. Lalani AS, Masters J, Zeng W, Barrett J, Pannu R, Everett H, Arendt CW, McFadden G: Use of chemokine receptors by poxviruses. Science 286:1968-71, 1999.
29. Hopkins, DR: Princes and Peasants: smallpox in history. University of Chicago, 1983.
30. Gonzalez E., Bamshad M., Sato N., Mummidi S., Dhanda R., Catano G., Cabrera S., McBride M., Cao X.H., Merrill G., O'Connell P., Bowden D.W., Freedman B.I., Anderson S.A., Walter E.A., Evans J.S., Stephan K.T., Clark R.A., Tyagi S., Ahuja S.S., Dolan M.J., Ahuja S.K. Race-specific HIV-1 disease-modifying effects associated with CCR5 haplotypes. Proc Natl Acad Sci USA. 96:1999;12004.
31. Lu Y, Nerurkar VR, Dashwood WM, Woodward CL, Ablan S, Shikuma CM, Grandinetti A, Chang H, Nguyen HT, Wu Z, et al. Genotype and allele frequency of a 32-base pair deletion mutation in the CCR5 gene in various ethnic groups: absence of mutation among Asians and Pacific Islanders. Inter J Infect Dis 3:186-91, 1999.
32. Lucotte G., Mercier G., Smets P. Elevated frequencies of the mutant allele delta 32 at the CCR5 gene in Ashkenazi Jews. AIDS Res Hum Retrov. 15:1999;1.
33. Kantor R, Gershoni JM: Distribution of the CCR5 gene 32-base pair deletion in Israeli ethnic groups. J Acquir Immune Defic Synd Hum Retrovirol 20:81, 1999.